Article
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
Science (New York, N.Y.) - 23 Aug 1991
Heitman J, Movva N R, Hall M N
Abstract excerpt
FK506 and rapamycin are related immunosuppressive compounds that block helper T cell activation by interfering with signal transduction. In vitro, both drugs bind and inhibit the FK506-binding protein (FKBP) proline rotamase. Saccharomyces cerevisiae cells treated with rapamycin irreversibly arrested in the G1 phase of the cell cycle. An FKBP-rapamycin complex is concluded to be the toxic agent because (i)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
